Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial

BACKGROUND: Clinical practice guidelines recommend administering antenatal corticosteroids (ACS), either betamethasone or dexamethasone, to women at risk of preterm birth at less than 35 weeks’ gestation. If women remain at risk of preterm birth seven or more days after an initial course of ACS, mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofer, Olivia J., Harding, Jane E., Tran, Thach, Crowther, Caroline A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863260/
https://www.ncbi.nlm.nih.gov/pubmed/35192656
http://dx.doi.org/10.1371/journal.pone.0263927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863260/
https://www.ncbi.nlm.nih.gov/pubmed/35192656
http://dx.doi.org/10.1371/journal.pone.0263927

Ejemplares similares